Abstract
In the vasculature, physiological levels of nitric oxide (NO) protect against various stressors, including mechanical stretch. While endothelial NO production in response to various stimuli has been studied extensively, the precise mechanism underlying stretch-induced NO production in venous endothelial cells remains incompletely understood. Using a model of continuous cellular stretch, we found that stretch promoted phosphorylation of endothelial NO synthase (eNOS) at Ser¹¹⁷⁷, Ser⁶³³ and Ser⁶¹⁵ and NO production in human umbilical vein endothelial cells. Although stretch activated the kinases AMPKα, PKA, Akt, and ERK1/2, stretch-induced eNOS activation was only inhibited by kinase-specific inhibitors of PKA and PI3K/Akt, but not of AMPKα and Erk1/2. Similar results were obtained with knockdown by shRNAs targeting the PKA and Akt genes. Furthermore, inhibition of PKA preferentially attenuated eNOS activation in the early phase, while inhibition of the PI3K/Akt pathway reduced eNOS activation in the late phase, suggesting that the PKA and PI3K/Akt pathways play distinct roles in a time-dependent manner. Finally, we investigated the role of these pathways in stretch-induced endothelial exocytosis and leukocyte adhesion. Interestingly, we found that inhibition of the PI3K/Akt pathway increased stretch-induced Weibel-Palade body exocytosis and leukocyte adhesion, while inhibition of the PKA pathway had the opposite effects, suggesting that the exocytosis-promoting effect of PKA overwhelms the inhibitory effect of PKA-mediated NO production. Taken together, the results suggest that PKA and Akt are important regulators of eNOS activation in venous endothelial cells under mechanical stretch, while playing different roles in the regulation of stretch-induced endothelial exocytosis and leukocyte adhesion.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
AMP-Activated Protein Kinases / genetics
-
AMP-Activated Protein Kinases / metabolism
-
Cell Adhesion / drug effects
-
Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
-
Cyclic AMP-Dependent Protein Kinases / genetics*
-
Cyclic AMP-Dependent Protein Kinases / metabolism
-
Exocytosis / drug effects
-
Gene Expression Regulation
-
Human Umbilical Vein Endothelial Cells / cytology
-
Human Umbilical Vein Endothelial Cells / metabolism*
-
Humans
-
Leukocytes / cytology
-
Leukocytes / drug effects
-
Mechanotransduction, Cellular
-
Mitogen-Activated Protein Kinase 1 / genetics
-
Mitogen-Activated Protein Kinase 1 / metabolism
-
Mitogen-Activated Protein Kinase 3 / genetics
-
Mitogen-Activated Protein Kinase 3 / metabolism
-
Nitric Oxide / biosynthesis
-
Nitric Oxide Synthase Type III / genetics*
-
Nitric Oxide Synthase Type III / metabolism
-
Phosphatidylinositol 3-Kinases / genetics
-
Phosphatidylinositol 3-Kinases / metabolism
-
Phosphorylation
-
Protein Kinase Inhibitors / pharmacology
-
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
-
Proto-Oncogene Proteins c-akt / genetics*
-
Proto-Oncogene Proteins c-akt / metabolism
-
RNA, Small Interfering / genetics
-
RNA, Small Interfering / metabolism
-
Stress, Mechanical
Substances
-
Protein Kinase Inhibitors
-
RNA, Small Interfering
-
Nitric Oxide
-
NOS3 protein, human
-
Nitric Oxide Synthase Type III
-
Proto-Oncogene Proteins c-akt
-
Cyclic AMP-Dependent Protein Kinases
-
MAPK1 protein, human
-
Mitogen-Activated Protein Kinase 1
-
Mitogen-Activated Protein Kinase 3
-
AMP-Activated Protein Kinases
-
PRKAA1 protein, human
Grants and funding
Jincai Luo is supported by research grants from the Major State Basic Research Development Program of China (No. 2012CB945100) and the National Science Funds (No. 81170098, No. 81070115 and Project 31221002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.